John McLaughlin insider trades

Open-market stock purchases and sales by John McLaughlin, Director at Sonoma Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 6, 2013.

Recent trades

DateStockTradeValue
Jan 2, 2026SNOA Sonoma Pharmaceuticals, IncBought (not open market)$36.8K

Companies traded

  • SNOA Sonoma Pharmaceuticals, Inc: other filings, last Jan 2, 2026
  • OCLS Oculus Innovative Sciences, Inc: other filings, last Nov 29, 2016

Get free alerts when John McLaughlin files a new trade →